Irritable bowel syndrome: Psychological comorbidities and cognitive behavioural therapy. A review of the literature

Gastrointestinal Nursing

Volumn 10, Issue 10, 2012, Pages 44-50

  Dainty, Andrew David ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871825287     PISSN: 14795248     EISSN: None     Source Type: Journal    
DOI: 10.12968/gasn.2012.10.10.44     Document Type: Review

References (55)

1. Badia X, Balboa A, Baro E, Caldwell E, Cucala M, Mearin F (2002) Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 20(11): 749-58. (Pubitemid 35034443)
2. Bass C, Peveler R, House A (2001) Somatoform disorders: severe psychiatric illnesses neglected by psychiatrists. Br J Psychiatry 179: 11-4.
3. Beck A (1976) Cognitive therapy and the emotional disorders. International Universities Press, New York.
4. Blanchard E, Lackner J, Sanders K et al (2007) A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome. Behav Res Ther 45(4): 633-48. (Pubitemid 46282624)
5. Bogalo L, Moss-Morris R (2006) The effectiveness of homework tasks in an irritable bowel syndrome cognitive behavioural self-management programme. NZ J Psychol 35(3): 120-5.
6. Boutron I, Moher D, Tugwell P et al (2005) A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol 58(12): 1233-40. (Pubitemid 41608539)
7. Boyce P, Talley N, Balaam B, Koloski N, Truman G (2003) A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol 98(10): 2209-18. (Pubitemid 37305361)
8. CONSORT (2012) Consolidated standards of reporting trials. www.consort-statement.org (accessed 25 October 2012).
9. Craske M, Wolitzky-Taylor K, Labus J et al (2011) A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther 49(6-7): 413-21.
10. Creed F, Craig T, Farmer R (1988) Functional abdominal pain, psychiatric illness and life events. Gut 29(2): 235-42. (Pubitemid 18078894)
11. Delvaux M, Denis P, Allemand H (1997) Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. Eur J Gastroenterol Hepatol 9(4): 345-52. (Pubitemid 27188632)
12. Drossman D, Toner B, Whitehead W et al (2003) Cognitivebehavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 125(1): 19-31. (Pubitemid 36799103)
13. El-Serag H, Olden K, Bjorkman D (2002) Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 16(6): 1171-85. (Pubitemid 34680762)
14. Francis C, Morris J, Whorwell P (1997) The irritable bowel severity scoring system. A simple method of monitoring irritable bowel syndrome and it's progress. Aliment Pharmacol Ther 11(1): 395-402. (Pubitemid 27183522)
15. Gaylord S, Palsson O, Garland E et al (2011) Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol 106(9): 1678-88.
16. Gralnek I, Hays R, Kilbourne A, Naliboff B, Mayer E (2000) The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119(3): 654-60.
17. Guthrie E, Barlow J, Fernandes L et al (2004) Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome. Psychosom Med 66(4): 578-82. (Pubitemid 38971254)
18. Hahn B, Kirchdoerfer L, Fullerton S, Mayer E (1997) Patientperceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 11(3): 553-9. (Pubitemid 27286958)
19. Halder S, Fett S, Locke G, Melton L, Talley N, Zinsmeister A (2004) Impact of functional gastrointestinal disorders on health-related quality of life: a population-based casecontrol study. Aliment Pharmacol Ther 19(2): 233-42. (Pubitemid 38174892)
20. Hassett A, Gevirtz R (2009) Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine. Rheum Dis Clin North Am 35(2): 393-407.
21. Hatcher S, Arroll B (2008) Assessment and management of medically unexplained symptoms. BMJ 336(7653): 1124-8. (Pubitemid 351731744)
22. Heymann-Mönnikes I, Arnold R, Florin I, Herda C, Melfsen S, Mönnikes H (2000) The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol 95(4): 981-94. (Pubitemid 30196735)
23. Kennedy T, Jones R, Darnley S, Seed P, Wessely S, Chalder T (2005) Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: Randomised controlled trial. BMJ 331(7514): 435.
24. Lackner J, Jaccard J, Krasner S, Katz L, Gudleski G, Holroyd K (2008) Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: Clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol 6(8): 899-906.
25. Lackner J (2010) How can cognitive behavioural therapy help irritable bowel syndrome? Gastrointestinal Nursing 8(4): 11.
26. Levy R, Olden K, Naliboff B et al (2006) Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 130(5): 1447-58.
27. Ljótsson B, Hedman E, Andersson E et al (2011) Internetdelivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol 106(8): 1481-91.
28. Longstreth G, Wilson A, Knight K et al (2003) Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol 98(3): 600-7. (Pubitemid 36348532)
29. Lydiard R, Falsetti S (1999) Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials. Am J Med 107(5): 65-73.
30. Mahvi-Shirazi M, Fathi-Ashtiani A, Rasoolzade-Tabatabaei S, Amini M (2012). Irritable bowel syndrome treatment: cognitive behavioral therapy versus medical treatment. Arch Med Sci 8(1): 123-9.
31. Mai F (2004) Somatization Disorder: a practical review. Can J Psychiatry 49(10): 652-62. (Pubitemid 39524653)
32. National Institute for Health and Clinical Excellence [NICE] (2008) Irritable bowel syndrome in adults: Diagnosis and management of irritable bowel syndrome in primary care. NICE, London.
33. National Institute for Health Research [NIHR] (2012) Health Technology Assessment programme: PPI guidance. www.hta.ac.uk/PPIguidance (accessed 30 October 2012).
34. North C, Downs D, Clouse R et al (2004) The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2(9): 787-95. (Pubitemid 39200717)
35. North C, Hong B, Alpers D (2007) Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. World J Gastroenterol 13(14): 2020-7. (Pubitemid 46795836)
36. O'Mahony L, McCarthy J, Kelly P et al (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128(3): 541-51. (Pubitemid 40585355)
37. Payne A, Blanchard E (1995) A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. J Consult Clin Psychol 63(5): 779-86.
38. Royal College of Nursing [RCN] (2007) User involvement in research by nurses. RCN guidance. RCN, London.
39. Reme S, Stahl D, Kennedy T, Jones R, Darnley S, Chalder T (2011) Mediators of change in cognitive behaviour therapy and mebeverine for irritable bowel syndrome. Psychol Med 41(12): 2669-79.
40. Rome Foundation (2012) To Improve the lives of people with functional GI disorders. www.romecriteria.org/criteria/(accessed 25 October 2012).
41. Ryle J (1928) An address on chronic spasmodic affections of the colon and the diseases which they simulate. Lancet 212(5492): 1115-9.
42. Schmulson M, Chang L (1999) Diagnostic approach to the patient with irritable bowel syndrome. Am J Med 107(5): 20-6.
43. Spiller R, Aziz Q, Creed F et al (2007) Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 56(12): 1770-98. (Pubitemid 350206308)
44. Stam R, Akkermans L, Wiegant V (1997) Trauma and the gut: interactions between stressful experience and intestinal function. Gut 40(6): 704-9. (Pubitemid 27305460)
45. Thabane M, Kottachchi D, Marshall J (2007) Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 26(4): 533-44.
46. Tkachuk G, Graff L, Martin G, Bernstein C (2003) Randomized controlled trial of cognitive-behavioral group therapy for irritable bowel syndrome in a medical setting. J Clin Psychol Med Settings 10(1): 57-69. (Pubitemid 36546382)
47. Toner B (1994) Cognitive-behavioral treatment of functional somatic syndromes: integrating gender issues. Cogn Behav Pract 1(1): 157-78.
48. Toner B, Stuckless N, Ali A, Downie F, Emmott S, Akman D (1998) The development of a cognitive scale for functional bowel disorders. Psychosom Med 60(4): 492-7. (Pubitemid 28354851)
49. Toner B, Segal Z, Emmott S, Myran D (2000) Cognitivebehavioral treatment of irritable bowel syndrome: The brain-gut connection. Guilford Press, New York.
50. Toner B (2005) Cognitive-behavioral treatment of irritable bowel syndrome. CNS Spectr 10(11): 883-90. (Pubitemid 41784933)
51. Van Dulmen A, Fennis J, Bleijenberg G (1996) Cognitivebehavioral group therapy for irritable bowel syndrome: effects and long-term follow-up. Psychosom Med 58(5): 508-14. (Pubitemid 26349897)
52. Vollmer A, Blanchard E (1998) Controlled comparison of individual versus group cognitive therapy for irritable bowel syndrome. Behav Ther 29(1): 19-33. (Pubitemid 28141251)
53. Wiklund I, Fullerton S, Hawkey C et al (2003) An irritable bowel syndrome specific symptom questionnaire: development and validation. Scand J Gastroenterol 38(9): 947-54. (Pubitemid 37153623)
54. Wilson S, Roberts L, Roalfe A, Bridge P, Singh S (2004) Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 54(504): 495-502. (Pubitemid 38931344)
55. Zijdenbos I, De Wit N, Van der Heijden G, Rubin G, Quartero A (2009) Cochrane Review: Psychological treatments for the management of irritable bowel syndrome. John Wiley and Sons, Chichester.